桂林三金 (002275)

Guilin Sanjin Pharmaceutical Co.,Ltd

ASZ

Tags

Innovative DrugsPharmaceutical ManufacturingFace Mask ProtectionHigh-Performing StocksMargin Trading and Securities LendingHigh-Dividend Stocks

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 58756.86
  • Circulating A-Shares(W): 55904.13
  • Earnings Per Share(RMB): 0.6600
  • Net Assets Per Share(RMB): 5.5226
  • Operating Revenue(W RMB): 146238.21
  • Total Profit(W RMB): 46954.39
  • Net Profit Attributable to Parent(W RMB): 38522.72
  • Net Profit Growth Rate(%): 0.35
  • Weighted Return on Equity(%): 12.2700
  • Operating Cash Flow Per Share(RMB): 0.7350
  • Undistributed Profit Per Share(RMB): 2.7831
  • Capital Reserve Per Share(RMB): 1.1438

2. Main Business

The main business covers:

  • Research, manufacturing and sales of Chinese patent medicines

3. Company Basic Information

  • Company Name: Guilin Sanjin Pharmaceutical Co., Ltd.
  • Listing Date: 2009-07-10
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 9 Renmin South Road, Lingui District, Guilin City, Guangxi Zhuang Autonomous Region
  • Website: www.sanjin.com.cn
  • Company Profile: The company was approved by the People's Government of Guangxi Zhuang Autonomous Region on December 26, 2001, and was restructured from “Guilin Sanjin Pharmaceutical Group Co., Ltd.” to “Guilin Sanjin Pharmaceutical Co., Ltd.”. On December 28, 2001, the company completed the industrial and commercial change registration at the Guangxi Zhuang Autonomous Region Administration for Industry and Commerce and obtained the business license. Prior to this issuance, the shareholders of the company were Sanjin Group and 42 natural persons including Mr. Zou Jieming.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guilin Sanjin Group Co., Ltd. General Legal Person 36467.93 65.23
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 406.07 0.73
3 China Fortune Ze Pension Target Date 2035 Three-Year Holding Hybrid Fund of Funds (FOF) Class A Fund 0.41 0.00

5. Concept Sectors

  • Mask Protection
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • High-Dividend Stocks

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information